Yu-Lin Liu,Zhuo Xiang,Bo-Ya Zhang,Yu-Wei Zou,Gui-Lai Chen,Li Yin,Yan-Long Shi,Li-Li Xu,Jingwang Bi,Qiang Wang

Abstract:Although platinum-based chemotherapy is the frontline regimen for colorectal cancer (CRC), drug resistance remains a major challenge affecting its therapeutic efficiency. However, there is limited research on the correlation between chemotherapy resistance and lipid metabolism, including PIK3CA mutant tumors. In this present study, we found that PIK3CA-E545K mutation attenuated cell apoptosis and increased the cell viability of CRC with L-OHP treatment in vitro and in vivo. Mechanistically,...

APOA5 alleviates reactive oxygen species to promote oxaliplatin resistance in PIK3CA-mutated colorectal cancer